20th Anniversary of the First Cord Blood Transplant and 10th Anniversary of Netcord
ESH, Eurocord, Netcord, EBMT, UT MD Anderson Cancer Center, Duke University
INTERNATIONAL CONFERENCE ON
BIOLOGY AND CLINICAL APPLICATIONS OF CORD BLOOD CELLS
Chairs: J. Garcia, E. Gluckman, J. Kurtzberg, E.J. Shpall
16 - 19 October 2008, Mandelieu, France

 

 Preliminary Programme

 

Thursday, October 16

12:00 Registration  
     
Session 1 Cord blood transplant: banking, organization, regulatory issues – Chair: TBA  
14.00-14.15 Netcord organization J. Garcia (Barcelona)
14.15-14.30

Challenges in the international exchange of CBUs

M. Boo (Minneapolis)
14.30-14.45 Biological resource center P. Rebulla (Milan)
14.45-15.00 Report from Asia Cord

S. Kato (Tokyo)

15.00-15.15 Latin America E. Calderon (Mexico City)
15.15-15.30 London cord blood bank C. Navarrete (London)
15.30 - 16.00 Coffee-Break  
16.00-16.30 Sibling cord blood banking B. Lubin (Oakland)
16.30-17.00 The unrealized potential of umbilical cord blood units for unrelated donor hematopoietic cell transplantation L. Petz (Arcadia)
17.00-17.45 Debate: Is there a place for autologous cord blood banking?

L. Petz (Arcadia)
C. Camby (Paris)
G. Garrido  (Madrid)
Y. Beguin (Liège)

18.00

Opening Ceremony Celebration Cord Blood Transplant History

 
 

Guest of Honour: José Carreras

 
 

Special Guests: H. Broxmeyer, A. Auerbach, P. Rubinstein, J. Wagner, P. Wernet,
M. Benbunan, E. Gluckman, G. Sirchia, M. Contreras, J.J. Van Rood, J. Kurtzberg and Patients

 
  Birthday Party with music and dance  
 

Friday, October 17

Session 2 Stem cells from cord blood – Chair: TBA  
9.00-9.30

Cord blood-derived very small embryonic like (VSEL) stem cells

M. Ratajczak (Louisville)
9.30-10.00 Biology of cord blood stem cells P. Simmons (Houston)
10.00-10.30

Functional characterization of stem cell subpopulations in cord blood

G. Kögler (Düsseldorf)
10.30-11.00 Coffee-Break  
11.00-11.30 Embryonic like cells from umbilical cord blood C. McGuckin (Newcastle)
11.30-12.00

The umbilical cord as a stem cell source: cells derived from Wharton's Jelly

M.L. Weiss (Manhatten)
12.00-12.30

Notch signalling in haematopoietic stem cell differentiation: implications for cord blood transplantation

I. Bernstein (Seattle)
12.30-13.00 Title to be defined W. Fibbe (Leiden)
13.00-14.00 Buffet lunch and poster viewing  
Session 3 Cord Non hematopoietic stem cells – Chair: TBA  
14.00-14.30 Re-defining human circulating endothelial progenitor cells

M.C. Yoder (Indianapolis)

14.30-15.00 Early foetal MSC and maternal and foetal tissue repair N.M. Fisk (Brisbane)
15.00-15.30 Cord non hematopoietic stem cells P. Wernet (Düsseldorf)
15.30-16.00 Hepatic and non hematopoietic progenitors J. Nolta (Sacremento)
16.00-16.30 Cord blood to treat neurological diseases J. Kurtzberg (Durham)
16.30-17.00 Coffee-break and poster viewing  
17.00-17.30 Isolation and characterization of cells from human term placenta O. Parolini (Brescia)
17.30-18.00 Stem cell mobilization by beta2-agonists J.A. Cancelas (Cincinnati)
18.00-18.30 Biology of stem/progenitor cell production and process development F. Godia (Barcelona)
 

Saturday, October 18

Session 4 Immunological properties – Chair: TBA  
8.00-8.30 Umbilical cord blood-derived T cells expressing chimeric antigen receptor to target B-cell malignancies P. Dotti (Houston)
8.30-9.00 Immune properties of cord blood F. Falkengurg (Leiden)
9.00-9.30 Virus specific cord blood T cells for clinical use C. Bollard (Houston)
9.30-10.00 Natural killer cells in cord blood and stem cell transplantation R. Champlin (Houston)
10.00-10.30 Coffee-Break  
Session 5 Role of HLA in cord blood transplant – Chair: TBA  
10.30-11.00 Influence of KIR mismatching in the outcome of cord blood transplant R. Willemze (Leiden)
11.00-11.30 Role of HLA and cell dose in cord blood transplant

P. Rubinstein (New York)

11.30-12.30 Panel discussion on donor choice

J. Wagner (Minneapolis)
P. Rubinstein (New York)
E. Gluckman (Paris)
M. Horowitz (Milwaukee)

12.30-13.00 Cord Blood or non T-cell depleted Haploidentical Transplant for patients with hematological malignancies W. Arceze (Rome)
13.00 - 14.00 Lunch  
Session 6 New protocols for cord blood transplant  
14.00-14.30 Double cord blood transplant J. Wagner (Minneapolis)
14.30-15.00 Reduce intensity conditioning J. Barker (New York)
15.00-15.30 Direct intra-bone (IBM) transplant of cord blood cells F. Frassoni (Genoa)
Session 7 Cord blood transplant in children  
15.30-16.00 Leukaemia F. Locatelli (Pavia)
16.00-16.30 Haemoglobinopathies M. Walters (Oakland)
16.30-17.00 Coffee-Break  
17.00-18.30 Selected abstracts and poster presentation  
 

Sunday, October 19

Session 8 Graft facilitation - Homing – Chair: TBA  
8.30-9.00 Mechanistic insights into engraftment H.E. Broxmeyer (Indianapolis)
9.00-9.30 Regulation of stem cell homing, retention and mobilization T. Lapidot (Rehovot)
9.30-10.00 Stem cells and their niche: a leverage point for therapy D. Scadden (Boston)
10.00-10.30 Methods for promoting engraftment E.J. Shpall (Houston)
10.30-11.00 Coffee-Break  
Session 9 Clinical results of cord blood transplant Eurocord Studies  
11.00-11.30 Acute Leukaemia V. Rocha (Paris)
11.30-12.00 Lymphoma C.A. Rodrigues (São Paulo)
12.00-12.30 Hurler J. Boelens (Ultrech)
  End of the meeting  
     
 
*pending confirmation